©The Author(s) 2019.
World J Hepatol. Dec 27, 2019; 11(12): 752-760
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Table 4 Management and outcomes, n (%)
| GCH on native liver, n = 40 | GCH on allograft, n = 10 | |
| Management | ||
| Immunosuppression | 11 (28) | 4 (40) |
| Supportive care | 10 (25) | 0 (0) |
| Liver transplantation | 5 (13) | 1 (10) |
| Ganciclovir | 1 (3) | 1 (10) |
| Unknown | 13 (33) | 4 (40) |
| Outcomes | ||
| Survived | 25 (63) | 4 (40) |
| Died | 5 (13) | 2 (20) |
| Unknown | 10 (25) | 4 (40) |
- Citation: Matta B, Cabello R, Rabinovitz M, Minervini M, Malik S. Post-infantile giant cell hepatitis: A single center’s experience over 25 years. World J Hepatol 2019; 11(12): 752-760
- URL: https://www.wjgnet.com/1948-5182/full/v11/i12/752.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i12.752